Urology Cancer Center PC — Omaha, Nebraska

Urology Cancer Center PC is a clinical research site located in Omaha, Nebraska, United States 68130.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Urology Cancer Center PC has participated in 14 clinical trials with 9 currently active.

Therapeutic areas: Neck Squamous Cell Carcinoma of Unknown Primary, Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous Cell Carcinoma.

Sponsors: National Cancer Institute (NCI), Novartis Pharmaceuticals, SWOG Cancer Research Network.

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Urology Cancer Center PC?

Urology Cancer Center PC has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Urology Cancer Center PC conducted?

Urology Cancer Center PC has 14 clinical trials on record, with 9 currently active. Their work covers Neck Squamous Cell Carcinoma of Unknown Primary, Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous Cell Carcinoma.

Is Urology Cancer Center PC accredited by Crixeo Health?

Yes — Urology Cancer Center PC holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Urology Cancer Center PC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.